Unlocking the mystery of tau for treatment of neurodegenerative diseases

by Nagoya UniversityUnder normal physiological conditions, FUS and SFPQ interact in the nucleus of nerve cells and regulate the alternative splicing of MAPT by excising exon 10. When this functio

Updated on: July 01,2024

Unlocking the mystery of tau for treatment of neurodegenerative diseases

by Nagoya UniversityUnder normal physiological conditions, FUS and SFPQ interact in the nucleus of nerve cells and regulate the alternative splicing of MAPT by excising exon 10. When this functio

Updated on:July 01,2024

Get a free memory screening from the Alzheimer's foundation this November

by Cara MurezEarly detection of memory issues is important.It can help rule in or out a variety of health issues, includingvitamin deficiency, thyroid condition,sleep apnea,urinary t

Updated on: July 01,2024

Get a free memory screening from the Alzheimer's foundation this November

by Cara MurezEarly detection of memory issues is important.It can help rule in or out a variety of health issues, includingvitamin deficiency, thyroid condition,sleep apnea,urinary t

Updated on:July 01,2024

Couples and young-onset dementia: Study of coping offers hope for new interventions

by Massachusetts General HospitalCredit: CC0 Public DomainResearchers from Massachusetts General Hospital (MGH) have used a couples-based framework to describe the experiences of individuals diag

Updated on: June 01,2024

Couples and young-onset dementia: Study of coping offers hope for new interventions

by Massachusetts General HospitalCredit: CC0 Public DomainResearchers from Massachusetts General Hospital (MGH) have used a couples-based framework to describe the experiences of individuals diag

Updated on:June 01,2024

AI helping bring vital stroke care 'virtually to the patient's bedside'

JANUARY 19, 2024by Audrey Kirby,University of KentuckyJustin Fraser, M.D., and Muhammed Fawad Ishfaq, M.D., are able to quickly review patient scans through their phones. Credit: Lily Wilder/Uni

Updated on: March 13,2024

AI helping bring vital stroke care 'virtually to the patient's bedside'

JANUARY 19, 2024by Audrey Kirby,University of KentuckyJustin Fraser, M.D., and Muhammed Fawad Ishfaq, M.D., are able to quickly review patient scans through their phones. Credit: Lily Wilder/Uni

Updated on:March 13,2024

Tool to measure brain blood flow identifies tell-tale signs of dementia and Alzheimer's early

by COSTCredit: COSTA network of over 200 scientists, clinicians and industry partners developed a cost-effective diagnostic tool for measuring the tell-tale signs of dementia and Alzheimer's. The

Updated on: May 05,2024

Tool to measure brain blood flow identifies tell-tale signs of dementia and Alzheimer's early

by COSTCredit: COSTA network of over 200 scientists, clinicians and industry partners developed a cost-effective diagnostic tool for measuring the tell-tale signs of dementia and Alzheimer's. The

Updated on:May 05,2024

Brain plasticity study: Oxytocin drives development of neural connections in adult-born neurons

by Baylor College of MedicineCredit: Pixabay/CC0 Public DomainLearning a new task, mastering a musical instrument or being able to adapt to the constantly changing environment are all possible th

Updated on: February 21,2024

Brain plasticity study: Oxytocin drives development of neural connections in adult-born neurons

by Baylor College of MedicineCredit: Pixabay/CC0 Public DomainLearning a new task, mastering a musical instrument or being able to adapt to the constantly changing environment are all possible th

Updated on:February 21,2024

Alzheimer's disease is composed of four distinct subtypes

by Lund UniversityCredit: Unsplash/CC0 Public DomainAlzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can no

Updated on: April 16,2024

Alzheimer's disease is composed of four distinct subtypes

by Lund UniversityCredit: Unsplash/CC0 Public DomainAlzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can no

Updated on:April 16,2024

Digital solutions for dementia care

by Flinders UniversityFlinders University Associate Professor Kate Laver, ARC Discovery Early Career Research Fellow and occupational therapist. Credit: Flinders UniversityTelehealth delivery of

Updated on: May 09,2024

Digital solutions for dementia care

by Flinders UniversityFlinders University Associate Professor Kate Laver, ARC Discovery Early Career Research Fellow and occupational therapist. Credit: Flinders UniversityTelehealth delivery of

Updated on:May 09,2024

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on: November 11,2024

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on:November 11,2024

Alzheimer's breakthrough: Two short strings of amino acids could pave the way to new treatments

by Ryan O'byrne,University of AlbertaU of A neurologist Jack Jhamandas led a team that found a new treatment significantly improved memory in mice with Alzheimer's disease. The researche

Updated on: April 18,2024

Alzheimer's breakthrough: Two short strings of amino acids could pave the way to new treatments

by Ryan O'byrne,University of AlbertaU of A neurologist Jack Jhamandas led a team that found a new treatment significantly improved memory in mice with Alzheimer's disease. The researche

Updated on:April 18,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on: April 02,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on:April 02,2024

Leading AI chatbots show dementia-like cognitive decline in tests, raising questions about their future in medicine

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainAlmost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot ea

Updated on: January 18,2025

Leading AI chatbots show dementia-like cognitive decline in tests, raising questions about their future in medicine

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainAlmost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot ea

Updated on:January 18,2025